Long-term results of a randomized controlled trial in childhood IgA nephropathy.

Validity of the Oxford classification of IgA nephropathy in children. Pediatr Nephrol (2011) 1.17

Nationwide survey on current treatments for IgA nephropathy in Japan. Clin Exp Nephrol (2013) 0.96

Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children. Pediatr Nephrol (2015) 0.88

Warfarin slows deterioration of renal function in elderly patients with chronic kidney disease and atrial fibrillation. Clin Interv Aging (2013) 0.81

Risk factors for persistent proteinuria after a 2-year combination therapy for severe childhood IgA nephropathy. Pediatr Nephrol (2014) 0.79

Proteinuria during Follow-Up Period and Long-Term Renal Survival of Childhood IgA Nephropathy. PLoS One (2016) 0.78

Long-term morbidity of IgA nephropathy in children evaluated with newly proposed remission criteria in Japan. Clin Exp Nephrol (2015) 0.77

Successful therapy with tonsillectomy plus pulse therapy for the relapse of pediatric IgA nephropathy treated with multi-drugs combination therapy. Fukushima J Med Sci (2016) 0.75

IgA nephropathy with presentation of nephrotic syndrome at onset in children. Pediatr Nephrol (2016) 0.75

Inflammation in IgA nephropathy. Pediatr Nephrol (2017) 0.75

Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02

A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics (1976) 13.83

Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet (1999) 3.51

Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis (2000) 3.44

IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol (2007) 2.83

Predicting progression in IgA nephropathy. Am J Kidney Dis (2001) 2.47

Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol (2004) 2.47

Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial. Am J Kidney Dis (2008) 2.31

Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy. Nephrol Dial Transplant (2009) 2.27

Treatment of IgA nephropathy. Kidney Int (2006) 1.98

Pathophysiology and treatment of IgA nephropathy in children. Pediatr Nephrol (2001) 1.85

Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. J Am Soc Nephrol (2003) 1.70

Improved renal survival in Japanese children with IgA nephropathy. Pediatr Nephrol (2008) 1.67

Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease. Clin Nephrol (2002) 1.64

A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group. J Am Soc Nephrol (1999) 1.60

Can immunosuppressive drugs slow the progression of IgA nephropathy? Nephrol Dial Transplant (1995) 1.59

Factors predicting progression of IgA nephropathies. J Nephrol (2005) 1.51

The IgA nephropathy treatment dilemma. Kidney Int (2006) 1.39

Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial. Clin Nephrol (1986) 1.27

Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial. Clin J Am Soc Nephrol (2006) 1.24

Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy. Am J Kidney Dis (2000) 1.19

Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy. Am J Kidney Dis (2003) 1.14

Prognostic indicators in childhood IgA nephropathy. Nephron (1992) 1.11

Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study. Pediatr Nephrol (2008) 1.04

Alternate-day prednisone therapy in IgA nephropathy. Preliminary analysis of a prospective, randomized, controlled trial. Contrib Nephrol (1993) 1.04

Evidence-based assessment of treatment options for children with IgA nephropathies. Pediatr Nephrol (2001) 0.99

Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy. Nephrol Dial Transplant (2010) 0.93

Efficacy and safety of glucocorticoids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials. Am J Nephrol (2009) 0.90

Efficacy and safety of lisinopril for mild childhood IgA nephropathy: a pilot study. Pediatr Nephrol (2008) 0.85

Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun (2010) 2.20

The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int (2010) 2.14

Acute renal failure due to obstructive uric acid stones associated with acute gastroenteritis. Pediatr Nephrol (2009) 2.09

Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol (2005) 2.08

Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol (2012) 1.95

Genotype-phenotype correlations in alternating hemiplegia of childhood. Neurology (2014) 1.82

Improved renal survival in Japanese children with IgA nephropathy. Pediatr Nephrol (2008) 1.67

Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol (2011) 1.67

The diagnostic utility of exome sequencing in Joubert syndrome and related disorders. J Hum Genet (2012) 1.64

The lack of cyclin kinase inhibitor p27(Kip1) ameliorates progression of diabetic nephropathy. J Am Soc Nephrol (2003) 1.63

Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis. Pediatr Nephrol (2013) 1.60

Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. Am J Physiol Renal Physiol (2008) 1.59

A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet (2012) 1.58

A deep intronic mutation in the SLC12A3 gene leads to Gitelman syndrome. Pediatr Res (2009) 1.57

Identification of FOXP3-negative regulatory T-like (CD4(+)CD25(+)CD127(low)) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Clin Immunol (2011) 1.57

Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial. Pediatr Nephrol (2014) 1.53

Henoch-Schonlein purpura presenting duodenal involvement similar to superior mesenteric artery syndrome in a girl. Eur J Pediatr (2006) 1.51

Rituximab in refractory nephrotic syndrome. Pediatr Nephrol (2009) 1.51

Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria. Nephron (2014) 1.50

Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children. Pediatr Nephrol (2009) 1.49

Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome. Pediatr Nephrol (2014) 1.46

Biopsy timing and Oxford classification variables in childhood/adolescent IgA nephropathy. Pediatr Nephrol (2014) 1.43

An infantile case of Hinman syndrome with severe acute renal failure. Clin Exp Nephrol (2008) 1.42

Unexpectedly high prevalence of pretransplant abnormal glucose tolerance in pediatric kidney transplant recipients. Pediatr Transplant (2006) 1.41

Two-step transplantation for primary hyperoxaluria: a winning strategy to prevent progression of systemic oxalosis in early onset renal insufficiency cases. Pediatr Transplant (2014) 1.40

Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice. Arthritis Rheum (2005) 1.40

Treatment strategies for Henoch-Schönlein purpura nephritis by histological and clinical severity. Pediatr Nephrol (2011) 1.39

Superior mesenteric artery syndrome: risk factor for duodenal involvement in Henoch-Schönlein purpura. Pediatr Int (2011) 1.39

Renal biopsy criterion in children with asymptomatic constant isolated proteinuria. Nephrol Dial Transplant (2012) 1.38

Usefulness of magnifying endoscopy with narrow-band imaging for determining gastric tumor margin. J Gastroenterol Hepatol (2010) 1.38

Henoch-Schönlein purpura nephritis with nephrotic state in children: predictors of poor outcomes. Pediatr Nephrol (2011) 1.34

Age, gender, and body length effects on reference serum creatinine levels determined by an enzymatic method in Japanese children: a multicenter study. Clin Exp Nephrol (2011) 1.31

Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial. Clin J Am Soc Nephrol (2006) 1.24

Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome. Nephrol Dial Transplant (2008) 1.21

Late-onset cases of familial hemophagocytic lymphohistiocytosis with missense perforin gene mutations. Am J Hematol (2007) 1.20

Posterior reversible encephalopathy syndrome in children: its high prevalence and more extensive imaging findings. Am J Kidney Dis (2006) 1.19

Posterior reversible encephalopathy syndrome in children with kidney diseases. Pediatr Nephrol (2011) 1.18

Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010. Clin Exp Nephrol (2013) 1.17

Validity of the Oxford classification of IgA nephropathy in children. Pediatr Nephrol (2011) 1.17

Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine. Pediatr Nephrol (2010) 1.15

Conversion of one-step to two-step self-etch adhesives for improved efficacy and extended application. Am J Dent (2005) 1.15

Elevation of serum Krebs von den Lunge-6 levels in patients with tubulointerstitial nephritis and uveitis syndrome. Am J Kidney Dis (2006) 1.14

The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients. Pediatr Nephrol (2002) 1.13

Atypical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome. Pediatr Nephrol (2012) 1.12

Microtensile dentin bond strength of self-etching resins: effect of a hydrophobic layer. Oper Dent (2005) 1.11

Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol (2013) 1.10

Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int (2002) 1.10

The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol (2003) 1.09